SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-20-043289
Filing Date
2020-12-17
Accepted
2020-12-17 17:29:59
Documents
1
Period of Report
2020-12-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 13647
  Complete submission text file 0001213900-20-043289.txt   15596
Mailing Address C/O KBL HEALTHCARE INC 645 MADISON AVE NEW YORK NY 10022
Business Address
KRAUSS MARLENE (Reporting) CIK: 0001033308 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38105 | Film No.: 201397177

Mailing Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019
Business Address 150 WEST 56TH STREET SUITE 5901 NEW YORK NY 10019 212-319-5555
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 527 STANTON CHRISTIANA ROAD NEWARK DE 19713
Business Address 527 STANTON CHRISTIANA ROAD NEWARK DE 19713 3025022727
KBL IV SPONSOR LLC (Reporting) CIK: 0001706868 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38105 | Film No.: 201397178